Home > Search: Haemophilus Influenzae type b Conjugate Vaccine

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Haemophilus Influenzae type b Conjugate Vaccine All Topic Areas 1 - 10 of 652  more >> Haemophilus Influenzae type b Conjugate Vaccine ActHIB HibTITER PedvaxHIB Haemophilus influenzae Serotype b (Hib) Infection Pneumococcal Vaccine Haemophilus ducreyi Infection Vaccine Immunization Polio Vaccine & Cancer Articles 1 - 5 of 53  more >> Ramsay Hunt Syndrome Type I Information Page Ramsay Hunt syndrome type I, also known as herpes zoster oticus, is a common complication of shingles. Shingles is an infection caused by the varicella-zoster virus, which is the virus that causes chickenpox. Shingles occurs in people who have had chickenpox and represents a reactivation of the dormant varicella-zoster virus. Ramsay Hunt syndrome type I, which is caused by the spread of the varicella-zoster virus to facial nerves, is characterized by intense ear pain, a rash around the ear,... National Institute of Neurological Disorders and Stroke, NIH, HHS Promising West Nile Virus Vaccine Protects Monkeys Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with proteins from the West Nile virus. The NIAID research team replaced proteins in a virus known as dengue type 4 with the corresponding West Nile virus proteins, creating a hybrid virus vaccine that protects monkeys from West Nile infection, they report in a paper to be published in the September issue of the... National Institutes of Health First U.S. Tuberculosis Vaccine Trial in 60 Years Begins A new vaccine, made with several proteins from the bacterium that causes tuberculosis (TB), will soon enter the first phase of human safety testing. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has supported research on the candidate vaccine from its earliest stages. The trial will be conducted in the United States by Seattle biotechnology company Corixa and GlaxoSmithKline Biologicals, a vaccine manufacturer headquartered in... National Institutes of Health Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox A mild, experimental smallpox vaccine known as modified vaccinia Ankara (MVA) is nearly as effective as the standard smallpox vaccine in protecting monkeys against monkeypox, a study by researchers of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has found. Monkeypox is used to test the effectiveness of a smallpox vaccine because of its similarity to the smallpox virus. The study appears in the March 11 issue of Nature. "These... National Institutes of Health Intranasal SARS Vaccine Protects Monkeys from Infection A single dose of a test vaccine sprayed into the nose protects monkeys against the SARS virus, according to Alexander Bukreyev, Ph.D., Peter Collins, Ph.D., and coworkers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The study, published in the June 26 issue of the British journal The Lancet, is the third recently issued by NIAID that describes a promising candidate vaccine against SARS. This vaccine differs from the... National Institutes of Health Organizations 1 - 3 of 3 Vaccine Information for the Public - http://www.vaccineinformation.org/ National Vaccine Program Office - The HIV Vaccine Trials Network - http://www.hvtn.org/ News 1 - 5 of 3437  more >> Actions Taken On HPV Vaccine Proposals In Kentucky, Massachusetts, New Mexico, Ohio, South Dakota, Virginia MedicalNewsToday - Mon, 05 Mar 2007 02:00 EST Wyeth Applauds Governments' Decision To Fund Pneumococcal Vaccine For Developing Countries MedicalNewsToday - Sat, 10 Feb 2007 08:00 EST Iomai Vaccine For Travelers' Diarrhea Blunts Severity Of Disease In Clinical Study MedicalNewsToday - Tue, 06 Mar 2007 08:00 EST Vaccine may fight different bird flu strains MSNBC - Tue, 06 Mar 2007 02:00 EST Parents Question HPV Vaccine Washington Post - Sun, 04 Mar 2007 05:00 EST Clinical Trials 1 - 5 of 3132  more >> Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines, Each Administered at 2, 4, 6, and 12 to 15 Months of Age. ClinicalTrials.gov Identifier: NCT00134719 - Active, not recruiting Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y. Study to Eliminate Hib Carriage in Rural Alaska Native Villages ClinicalTrials.gov Identifier: NCT00153556 - Completed Haemophilus influenzae type B; Carrier State Immunogenicity and Safety of PENTAXIM™ in Indian Population ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B Dose Ranging Study of 3 Formulations of Hib-MenCY-TT Vaccine and 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2, 3, and 4 Months of Age. ClinicalTrials.gov Identifier: NCT00129116 - Completed Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y. Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine, Each Administered at 2, 4, and 6 Months of Age; and Compared to Licensed Meningococcal Serogroups A, C, Y, and W-135 Polysaccharide Vaccine Administered at ClinicalTrials.gov Identifier: NCT00129129 - Completed Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.

GoldBambooTM Your Integrative Health and Wellness Resource December 4, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.